<!DOCTYPE html>
<html lang="tr"><head>
<script src="pituitary-diseases_files/libs/clipboard/clipboard.min.js"></script>
<script src="pituitary-diseases_files/libs/quarto-html/tabby.min.js"></script>
<script src="pituitary-diseases_files/libs/quarto-html/popper.min.js"></script>
<script src="pituitary-diseases_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="pituitary-diseases_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="pituitary-diseases_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="pituitary-diseases_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="pituitary-diseases_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar BalcÄ±">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="pituitary-diseases_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="pituitary-diseases_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="pituitary-diseases_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="pituitary-diseases_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="pituitary-diseases_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="pituitary-diseases_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="pituitary-diseases_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar BalcÄ± 
</div>
</div>
</div>

</section>
<section id="harvey-williams-cushing" class="title-slide slide level1 center">
<h1>Harvey Williams Cushing</h1>
<p><img data-src="img%5CPituitary-Diseases0.jpg"></p>
<p><strong>first anaesthetic chart</strong></p>
<p><strong>clinical use of X-rays</strong></p>
<p><strong>relationship between systolic blood pressure and cranial pressure</strong></p>
<p><strong>application of electrical coagulation to neurosurgery</strong></p>
<p><strong>https://en.wikipedia.org/wiki/Harvey_Cushing</strong></p>
<p><img data-src="img%5CPituitary-Diseases1.png"></p>
<p><strong>http://www.whonamedit.com/doctor.cfm/980.html</strong></p>
<p><img data-src="img%5CPituitary-Diseases2.png"></p>
<p><img data-src="img%5CPituitary-Diseases3.png"></p>
<p><img data-src="img%5CPituitary-Diseases4.png"></p>
<p><strong>Ann R Coll Surg Engl. 1969 Apr;44(4):180-1.</strong></p>
<p><img data-src="img%5CPituitary-Diseases5.png"></p>
<p><strong>Ann Surg. 1909 Dec;50(6):1002-17.</strong></p>
<p><img data-src="img%5CPituitary-Diseases6.png"></p>
<p><strong>Ann Surg. 1909 Dec;50(6):1002-17.</strong></p>
<p><img data-src="img%5CPituitary-Diseases7.png"></p>
<p><img data-src="img%5CPituitary-Diseases8.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases9.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases10.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases11.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases12.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases13.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases14.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
<p><img data-src="img%5CPituitary-Diseases15.png"></p>
<p><strong>Pituitary. 2010 Dec;13(4):324-8.</strong></p>
</section>

<section id="davutun-golyatÄ±-Ã¶ldÃ¼rmesi-i.samuel" class="title-slide slide level1 center">
<h1>Davutâun GolyatâÄ± ÃldÃ¼rmesi (I.Samuel)</h1>
<p><strong>1.Sa.17: 4 Filist ordugahÄ±ndan GatlÄ± Golyat adÄ±nda usta bir dÃ¶vÃ¼ÅÃ§Ã¼ortaya Ã§Ä±ktÄ±. </strong> <strong>Boyu </strong> <strong>altÄ± arÅÄ±n bir karÄ±ÅtÄ±*fe*.D Not 17:4 âAltÄ± arÅÄ±n bir karÄ±Åâ: </strong> <strong>YaklaÅÄ±k 2.9 m</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 5 BaÅÄ±na tunÃ§* miÄfer takmÄ±Å, pullu bir zÄ±rh kuÅanmÄ±ÅtÄ±. </strong> <strong>TunÃ§ zÄ±rhÄ±n aÄÄ±rlÄ±ÄÄ±</strong> __ beÅ bin Åekeldi*ff*.D Not 17:5 âBeÅ bin Åekelâ: __ <strong>YaklaÅÄ±k 57.5 kg</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 6 BaldÄ±rlarÄ± zÄ±rhlarla korunmuÅtu. OmuzlarÄ± arasÄ±nda tunÃ§ bir pala asÄ±lÄ±ydÄ±.</strong></p>
<p><strong>1.Sa.17: 7 MÄ±zraÄÄ±nÄ±n sapÄ± dokumacÄ± tezgahÄ±nÄ±n sÄ±rÄ±ÄÄ± gibiydi. </strong> <strong>MÄ±zraÄÄ±ndemir baÅÄ±nÄ±n aÄÄ±rlÄ±ÄÄ±</strong> __ altÄ± yÃ¼z Åekeldi*fg*. GolyatâÄ±n Ã¶nÃ¼sÄ±ra kalkanÄ±nÄ± taÅÄ±yan bir adam yÃ¼rÃ¼yordu.D Not 17:7 âAltÄ± yÃ¼z Åekelâ: __ <strong>YaklaÅÄ±k 6.9 kg</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 8 Golyat durup Ä°srail ordusuna, âNeden savaÅ dÃ¼zeni aldÄ±nÄ±z?â diye haykÄ±rdÄ±, âBen Filistliâyim, sizse Saulâun kÃ¶lelerisiniz. AranÄ±zdan karÅÄ±ma Ã§Ä±kacak birini seÃ§in.</strong></p>
<p><strong>1.Sa.17: 38 Sonra kendi giysilerini Davutâa verdi; baÅÄ±na tunÃ§ miÄfer taktÄ±, ona bir zÄ±rh giydirdi.</strong></p>
<p><strong>1.Sa.17: 39 Davut giysilerinin Ã¼zerine kÄ±lÄ±cÄ±nÄ± kuÅanÄ±p yÃ¼rÃ¼meye Ã§alÄ±ÅtÄ±. ÃÃ¼nkÃ¼ bu giysilere alÄ±ÅÄ±k deÄildi. Saulâa, âBunlarla yÃ¼rÃ¼yemiyorumâ dedi, âÃÃ¼nkÃ¼ alÄ±ÅÄ±k deÄilim.â Sonra giysileri Ã¼zerinden Ã§Ä±kardÄ±.</strong></p>
<p><strong>1.Sa.17: 40 DeÄneÄini alÄ±p dereden beÅ Ã§akÄ±l taÅÄ± seÃ§ti. BunlarÄ± Ã§oban daÄarcÄ±ÄÄ±nÄ±n cebine koyduktan sonra </strong> <strong>sapanÄ±nÄ± alÄ±p Filistli Golyatâa doÄru ilerledi</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 48 Golyat saldÄ±rmak amacÄ±yla Davutâa doÄru ilerledi. Davut daonunla dÃ¶vÃ¼Åmek Ã¼zere hemen Filist cephesine doÄru koÅtu.</strong></p>
<p><strong>1.Sa.17: 49 </strong> <strong>Elini daÄarcÄ±ÄÄ±na sokup bir taÅ Ã§Ä±kardÄ±, sapanla fÄ±rlattÄ±.TaÅ Filistliânin alnÄ±na Ã§arpÄ±p saplandÄ±. Filistli yÃ¼zÃ¼koyun yere dÃ¼ÅtÃ¼.</strong></p>
<p><strong>1.Sa.17: 50 BÃ¶ylece Davut Filistli GolyatâÄ± sapan ve taÅla yendi.Elinde kÄ±lÄ±Ã§ olmaksÄ±zÄ±n onu yere serdi.</strong></p>
<p><strong>1.Sa.17: 51 Sonra koÅup Ã¼zerine Ã§Ä±ktÄ±. GolyatâÄ±n kÄ±lÄ±cÄ±nÄ± tutupkÄ±nÄ±ndan Ã§ektiÄi gibi onu Ã¶ldÃ¼rdÃ¼ ve baÅÄ±nÄ± kesti.Kahraman GolyatâÄ±n Ã¶ldÃ¼ÄÃ¼nÃ¼ gÃ¶ren Filistliler kaÃ§tÄ±lar.</strong></p>
<p><strong>Pierre Puget âDavid, vainqueur de Goliathâ </strong></p>
<p><em>A History of Acromegaly </em> <strong>Pituitary 1999;2:7â28</strong></p>
<p><img data-src="img%5CPituitary-Diseases16.jpg"></p>
<p><strong>Undoubtedly Goliathâs great size was due to </strong> <strong>acromegaly </strong> <strong>secondary to a pituitary macroadenoma. This pituitary adenoma was apparently large enough to induce </strong> <strong>visual field deficits</strong> __ by its pressure on the optic chiasm, which made Goliath __ <strong>unable to follow the young David </strong> <strong>as he circled him. The </strong> <strong>stone entered Goliathâs cranial vault </strong> <strong>through a </strong> <strong>markedly thinned frontal bone</strong> <strong>, which resulted from enlargement of the frontal paranasal sinus, a frequent feature of acromegaly. The stone lodged in Goliathâs enlarged pituitary and caused a </strong> <strong>pituitary hemorrhage</strong> <strong>, resulting in </strong> <strong>transtentorial herniation and death</strong> <strong>.</strong></p>
<p><strong>Radiology. 1990 Jul;176(1):288. </strong></p>
<p><img data-src="img%5CPituitary-Diseases17.jpg"></p>
</section>

<section id="pituitary-diseases" class="title-slide slide level1 center">
<h1>Pituitary Diseases</h1>

</section>

<section id="serdar-balci-md" class="title-slide slide level1 center">
<h1>Serdar BALCI, MD</h1>

</section>

<section id="pituitary-gland" class="title-slide slide level1 center">
<h1>Pituitary gland</h1>
<ul>
<li><strong>small, bean-shaped </strong></li>
<li><strong>lies at the base of the brain within the sella turcica</strong></li>
<li><strong>Related to the hypothalamus</strong>
<ul>
<li><strong>stalk, composed of axons</strong></li>
<li><strong>venous plexus</strong></li>
</ul></li>
<li><strong>Anterior lobe (adenohypophysis)</strong></li>
<li><strong>Posterior lobe (neurohypophysis)</strong></li>
</ul>
</section>

<section id="anterior-pituitary-adenohypophysis" class="title-slide slide level1 center">
<h1>Anterior pituitary (adenohypophysis)</h1>
<ul>
<li><strong>Epithelial cells</strong></li>
<li><strong>Embryologically from the developing oral cavity</strong></li>
<li><strong>Normal histology:</strong>
<ul>
<li><strong>Cells containing basophilic cytoplasm</strong></li>
<li><strong>Eosinophilic cytoplasm</strong></li>
<li><strong>Poorly staining ( chromophobic ) cytoplasm</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CPituitary-Diseases18.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CPituitary-Diseases19.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CPituitary-Diseases20.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases21.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases22.jpg"></p>
</section>

<section id="pituitary-diseases-1" class="title-slide slide level1 center">
<h1>Pituitary Diseases</h1>
<ul>
<li><strong>Hyperpituitarism</strong>
<ul>
<li><strong>excessive secretion of trophic hormones</strong></li>
<li><strong>Anterior pituitary adenoma</strong></li>
</ul></li>
<li><strong>Hypopituitarism</strong>
<ul>
<li><p><strong>Deficiency of trophic hormones</strong></p></li>
<li><p><strong>Ischemic injury, surgery or radiation, and inflammatory reactions</strong></p></li>
<li><p><strong>Nonfunctional pituitary adenomas destruct normal structures</strong></p></li>
<li><p><strong>Local mass effects</strong></p></li>
<li><p><strong>Sellar expansion, bony erosion, and disruption of the diaphragma sellae</strong></p></li>
<li><p><strong>Compress decussating fibers in the optic chiasm</strong></p>
<ul>
<li><strong>lateral (temporal) visual fields, bitemporal hemianopsia</strong></li>
</ul></li>
<li><p><strong>Elevated intracranial pressure</strong></p>
<ul>
<li><strong>headache, nausea, and vomiting</strong></li>
</ul></li>
<li><p><strong>Extend into the base of the brain</strong></p>
<ul>
<li><strong>invasive pituitary adenoma</strong></li>
<li><strong>seizures or obstructive hydrocephalus</strong></li>
<li><strong>cranial nerve palsy</strong></li>
</ul></li>
<li><p><strong>Acute hemorrhage into an adenoma</strong></p>
<ul>
<li><strong>rapid enlargement of the lesion</strong></li>
<li><strong>pituitary apoplexy</strong></li>
<li><strong>rapidly fatal</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="hyperpituitarism" class="title-slide slide level1 center">
<h1>Hyperpituitarism</h1>
<ul>
<li><strong>The most common cause of hyperpituitarism is an adenoma arising in the anterior lobe</strong></li>
<li><strong>Less common causes</strong>
<ul>
<li><strong>Hyperplasia</strong></li>
<li><strong>carcinomas of the anterior pituitary</strong></li>
<li><strong>secretion of hormones by some extrapituitary tumors</strong></li>
<li><strong>Certain hypothalamic disorders</strong></li>
</ul></li>
</ul>
</section>

<section id="pathogenesis-of-pituitary-adenomas" class="title-slide slide level1 center">
<h1>Pathogenesis of Pituitary Adenomas</h1>
<ul>
<li><strong>Guanine nucleotideâbinding protein (G protein) mutations</strong></li>
<li><strong>critical role in signal transduction</strong>
<ul>
<li><strong>from cell surface receptors (e.g., growth hormoneâreleasing hormone receptor) to intracellular effectors (e.g., adenyl cyclase)</strong>
<ul>
<li><strong>generate second messengers (e.g., cAMP).</strong></li>
</ul></li>
<li><strong>encoded by the GNAS1 gene</strong></li>
</ul></li>
<li><strong>40% of growth hormoneâsecreting somatotroph cell adenomas and a minority of adrenocorticotropic hormone (ACTH)âsecreting corticotroph cell adenomas have GNAS1 mutations</strong></li>
</ul>
<p><img data-src="img%5CPituitary-Diseases23.png"></p>
<ul>
<li><strong>Familial pituitary adenomas</strong>
<ul>
<li><strong>MEN1, CDKN1B, PRKAR1A, and AIP</strong></li>
<li><strong>Germline inactivating mutations of the MEN1 gene</strong>
<ul>
<li><strong>multiple endocrine neoplasia syndrome type 1 (MEN-1)</strong></li>
</ul></li>
<li><strong>CDKN1B gene</strong>
<ul>
<li><strong>cell cycle checkpoint regulator p27 or KIP1</strong></li>
</ul></li>
<li><strong>Germline mutations of CDKN1B</strong>
<ul>
<li><strong>âMEN-1 likeâ syndrome who lack MEN1 abnormalities</strong></li>
</ul></li>
<li><strong>Aryl hydrocarbon receptorâinteracting protein (AIP)</strong>
<ul>
<li><strong>pituitary adenoma predisposition gene</strong></li>
<li><strong>GH-secreting adenomas at a younger age (before 35 years) than that typical for sporadic GH adenoma patients</strong></li>
</ul></li>
</ul></li>
<li><strong>Mutations of TP53</strong>
<ul>
<li><strong>associated with a propensity for aggressive behavior, such as invasion and recurrence</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CPituitary-Diseases24.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CPituitary-Diseases25.png"></p>
<p><strong>Macroadenomas &gt;1 cm</strong></p>
<p><strong>Microadenomas &lt;1 cm</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CPituitary-Diseases26.png"></p>
<p><strong>Pituitary adenoma is a well-circumscribed, soft lesion</strong></p>
<p><strong>Smaller tumors, be confined by the sella turcica</strong></p>
<p><strong>Larger lesions may compress the optic chiasm and adjacent structures</strong></p>
<p><strong>Erode the sella turcica and anterior clinoid processes</strong></p>
<p><strong>Extend locally into the cavernous and sphenoidal sinuses</strong></p>
<p><strong>30% of cases, nonencapsulated and infiltrate adjacent bone, dura, and (uncommonly) brain</strong></p>
<p><strong>Foci of hemorrhage and/or necrosis are common in larger adenomas</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CPituitary-Diseases27.png"></p>
<p><strong>Massive, nonfunctioning adenoma has grown far beyond the confines of the sella turcica and has distorted the overlying brain</strong></p>
<p><strong>Nonfunctioning adenomas tend to be larger at the time of diagnosis than those that secrete a hormone</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CPituitary-Diseases28.png"></p>
<p><strong>Relatively uniform, polygonal cells arrayed in sheets, cords, or papillae</strong></p>
<p><strong>Supporting connective tissue, or reticulin, is sparse</strong></p>
<p><strong>Soft, gelatinous consistency</strong></p>
<p><strong>Nuclei of the neoplastic cells may be uniform or pleomorphic</strong></p>
<p><strong>Mitotic activity usually is scanty</strong></p>
<p><strong>Cytoplasm of the constituent cells may be acidophilic, basophilic, or chromophobic, depending on the type and amount of secretory product within the cell, but it is fairly uniform throughout the neoplasm</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>anterior pituitary parenchyma</strong></p>
<p><strong>pituitary adenoma</strong></p>
<p><img data-src="img%5CPituitary-Diseases29.png"></p>
<p><img data-src="img%5CPituitary-Diseases30.png"></p>
<p><strong>Cellular monomorphism and the absence of a significant reticulin network distinguish pituitary adenomas from non-neoplastic anterior pituitary parenchyma</strong></p>
</section>

<section id="pituitary-adenomas" class="title-slide slide level1 center">
<h1>Pituitary Adenomas</h1>
<ul>
<li><strong>The functional status of the adenoma cannot be reliably predicted from its histologic appearance</strong></li>
<li><strong>Adenomas with TP53 mutations</strong>
<ul>
<li><strong>brisk mitotic activity</strong></li>
<li><strong>higher proliferation rates</strong></li>
<li><strong>Designated as âatypical adenomasâ</strong></li>
<li><strong>potential for aggressive behavior</strong></li>
</ul></li>
<li><strong>Composed of a single cell type and produce a single predominant hormone</strong></li>
<li><strong>Some pituitary adenomas can secrete two different hormones</strong>
<ul>
<li><strong>growth hormone and prolactin most common combination</strong></li>
<li><strong>rarely plurihormonal</strong></li>
</ul></li>
<li><strong>Functional</strong>
<ul>
<li><strong>Associated with hormone excess and clinical manifestations</strong></li>
</ul></li>
<li><strong>Nonfunctioning adenomas</strong>
<ul>
<li><strong>Mass effects, hypopituitarism</strong></li>
<li><strong>Demonstration of hormone production at the tissue level only, without clinical manifestations of hormone excess</strong></li>
</ul></li>
<li><strong>Truly âhormone negativeâ</strong>
<ul>
<li><strong>Absence of immunohistochemical reactivity or ultrastructural evidence of hormone production</strong></li>
</ul></li>
<li><strong>Nonfunctioning and hormone-negative adenomas</strong>
<ul>
<li><strong>come to clinical attention at a later stage</strong></li>
<li><strong>Macroadenomas</strong></li>
<li><strong>may cause hypopituitarism</strong></li>
</ul></li>
</ul>
<p><strong>Pituitary Adenomas</strong></p>

<img data-src="img%5CPituitary-Diseases31.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="prolactinomas" class="title-slide slide level1 center">
<h1>Prolactinomas</h1>
<p><strong>Most common type of hyperfunctioning pituitary adenoma</strong></p>
<p><strong>Range in size from small microadenomas to large, expansile tumors associated with considerable mass effect</strong></p>
<p><strong>Prolactin is demonstrable within the cytoplasm of the neoplastic cells by immunohistochemical techniques</strong></p>
</section>

<section id="hyperprolactinemia" class="title-slide slide level1 center">
<h1>Hyperprolactinemia</h1>
<ul>
<li><strong>amenorrhea, galactorrhea, loss of libido, and infertility</strong></li>
<li><strong>Diagnosed at an earlier stage in women of reproductive age</strong></li>
<li><strong>May be quite subtle in men and older women</strong>
<ul>
<li><strong>tumor may reach considerable size before coming to clinical attention</strong></li>
</ul></li>
<li><strong>Causes other than prolactin-secreting pituitary adenomas:</strong>
<ul>
<li><strong>pregnancy</strong></li>
<li><strong>high-dose estrogen therapy</strong></li>
<li><strong>renal failure</strong></li>
<li><strong>hypothyroidism</strong></li>
<li><strong>hypothalamic lesions</strong></li>
<li><strong>dopamine-inhibiting drugs (e.g., reserpine)</strong></li>
<li><strong>Stalk effect</strong>
<ul>
<li><strong>Any mass in the suprasellar compartment may disturb the normal inhibitory influence of hypothalamus on prolactin secretion, resulting in hyperprolactinemia</strong></li>
<li><strong>Mild elevations of serum prolactin (less than 200 Âµg/L) in a patient with a pituitary adenoma do not necessarily indicate a prolactin-secreting neoplasm</strong></li>
</ul></li>
</ul></li>
</ul>

<img data-src="img%5CPituitary-Diseases32.png" class="r-stretch"><p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="growth-hormoneproducing-somatotroph-cell-adenomas" class="title-slide slide level1 center">
<h1>Growth HormoneâProducing (Somatotroph Cell) Adenomas</h1>
<ul>
<li><p><strong>Second most common type of functional pituitary adenoma</strong></p>
<ul>
<li><strong>GH adenomas</strong></li>
<li><strong>Mixed GH+ PRL adenomas</strong></li>
</ul></li>
<li><p><strong>Clinical manifestations of excessive growth hormone may be subtle</strong></p></li>
<li><p><strong>Somatotroph cell adenomas may be quite large by the time they come to clinical attention</strong></p></li>
<li><p><strong>Composed of densely or sparsely granulated cells</strong></p></li>
<li><p><strong>Immunohistochemical staining demonstrates growth hormone within the cytoplasm of the neoplastic cells</strong></p></li>
<li><p><strong>Small amounts of immunoreactive prolactin often are present as well</strong></p></li>
<li><p><strong>Persistent hypersecretion of growth hormone</strong></p>
<ul>
<li><strong>Stimulates the hepatic secretion of insulin-like growth factor I (somatomedin C)</strong></li>
<li><strong>Causes many of the clinical manifestations</strong></li>
</ul></li>
<li><p><strong>Before the epiphyses close, prepubertal children</strong></p>
<ul>
<li><strong>Gigantism</strong>
<ul>
<li><strong>generalized increase in body size</strong></li>
<li><strong>disproportionately long arms and legs</strong></li>
</ul></li>
</ul></li>
<li><p><strong>After closure of the epiphyses</strong></p>
<ul>
<li><strong>Acromegaly</strong>
<ul>
<li><strong>Growth in soft tissues, skin, and viscera and in the bones of the face, hands, and feet</strong></li>
<li><strong>Prognathism</strong>
<ul>
<li><strong>Enlargement of the jaw results in its protrusion</strong></li>
<li><strong>Broadening of the lower face and separation of the teeth</strong></li>
</ul></li>
<li><strong>Hands and feet are enlarged</strong></li>
<li><strong>Broad, sausage-like fingers</strong></li>
</ul></li>
</ul></li>
<li><p><strong>Growth hormone excess</strong></p>
<ul>
<li><strong>abnormal glucose tolerance</strong></li>
<li><strong>diabetes mellitus</strong></li>
<li><strong>generalized muscle weakness</strong></li>
<li><strong>hypertension</strong></li>
<li><strong>arthritis</strong></li>
<li><strong>osteoporosis</strong></li>
<li><strong>congestive heart failure</strong></li>
</ul></li>
</ul>
</section>

<section id="adrenocorticotropic-hormoneproducing-corticotroph-cell-adenomas" class="title-slide slide level1 center">
<h1>Adrenocorticotropic HormoneâProducing (Corticotroph Cell) Adenomas</h1>
<ul>
<li><p><strong>Most are small (microadenomas) at the time of diagnosis</strong></p></li>
<li><p><strong>Stain positively with periodic acidâSchiff (PAS) stains</strong></p>
<ul>
<li><strong>accumulation of glycosylated ACTH protein</strong></li>
</ul></li>
<li><p><strong>Secretory granules can be detected by immunohistochemical methods</strong></p></li>
<li><p><strong>Electron microscopy they appear as membrane-bound, electron-dense granules averaging 300 nm in diameter</strong></p></li>
<li><p><strong>May be clinically silent</strong></p></li>
<li><p><strong>May cause hypercortisolism</strong></p>
<ul>
<li><strong>Cushing syndrome</strong></li>
<li><strong>stimulatory effect of ACTH on the adrenal cortex</strong></li>
</ul></li>
<li><p><strong>Cushing disease</strong></p>
<ul>
<li><strong>When the hypercortisolism is caused by excessive production of ACTH by the pituitary</strong></li>
</ul></li>
<li><p><strong>Nelson syndrome</strong></p>
<ul>
<li><strong>Large, clinically aggressive corticotroph cell adenomas may develop after surgical removal of the adrenal glands for treatment of Cushing syndrome</strong></li>
<li><strong>when adrenals removed surgically</strong></li>
<li><strong>loss of the inhibitory effect of adrenal corticosteroids on a preexisting corticotroph microadenoma</strong></li>
<li><strong>patients present with the mass effects of the pituitary tumor</strong></li>
</ul></li>
</ul>
</section>

<section id="gonadotroph-luteinizing-hormone-lhproducing-and-follicle-stimulating-hormone-fshproducing-adenomas" class="title-slide slide level1 center">
<h1>Gonadotroph (luteinizing hormone <a href="#/lh">LH</a>âproducing and follicle-stimulating hormone <a href="#/fsh">FSH</a>âproducing) adenomas</h1>
<p><strong>Difficult to recognize</strong></p>
<p><strong>Secrete hormones inefficiently and variably</strong></p>
<p><strong>Secretory products usually do not cause a recognizable clinical syndrome</strong></p>
<p><strong>Detected with mass effects</strong></p>
<p><strong>Immunoreactivity for the common gonadotropin Î±-subunit and the specific Î²-FSH and Î²-LH subunits; FSH usually is the predominant secreted hormone</strong></p>
</section>

<section id="thyrotroph-thyroid-stimulating-hormone-tshproducing-adenomas" class="title-slide slide level1 center">
<h1>Thyrotroph (thyroid-stimulating hormone <a href="#/tsh">TSH</a>âproducing) adenomas</h1>
<p><strong>1% of all pituitary adenomas and constitute a rare cause of hyperthyroidism</strong></p>
</section>

<section id="nonfunctioning-pituitary-adenomas" class="title-slide slide level1 center">
<h1>Nonfunctioning pituitary adenomas</h1>
<ul>
<li><strong>25% of all pituitary tumors</strong></li>
<li><strong>Characterized by mass effects</strong></li>
<li><strong>Hypopituitarism</strong></li>
<li><strong>Clinically silent counterparts of the functioning adenomas</strong>
<ul>
<li><strong>silent gonadotroph adenoma</strong></li>
</ul></li>
<li><strong>True hormone-negative (null cell) adenomas</strong>
<ul>
<li><strong>infrequent</strong></li>
</ul></li>
</ul>
</section>

<section id="pituitary-carcinomas" class="title-slide slide level1 center">
<h1>Pituitary carcinomas</h1>
<p><strong>Exceedingly rare</strong></p>
<p><strong>Local extension beyond the sella turcica</strong></p>
<p><strong>Distant metastases</strong></p>
</section>

<section id="hypopituitarism" class="title-slide slide level1 center">
<h1>Hypopituitarism</h1>
<p><strong>Loss or absence of 75% or more of the anterior pituitary parenchyma</strong></p>
<p><strong>Congenital (exceedingly rare)</strong></p>
<p><strong>Nonfunctioning pituitary adenomas</strong></p>
<ul>
<li><p><strong>Ischemic necrosis of the anterior pituitary</strong></p>
<ul>
<li><strong>Sheehan syndrome</strong>
<ul>
<li><strong>postpartum necrosis of the anterior pituitary</strong></li>
<li><strong>physiologic enlargement of the gland during pregnancy is not accompanied by an increase in blood supply from the low-pressure portal venous system</strong></li>
<li><strong>significant hemorrhage and hypotension during the peripartal period</strong></li>
<li><strong>posterior pituitary is not effected, receives its blood directly from arterial branches</strong></li>
</ul></li>
<li><strong>disseminated intravascular coagulation</strong></li>
<li><strong>sickle cell anemia</strong></li>
<li><strong>elevated intracranial pressure</strong></li>
<li><strong>traumatic injury</strong></li>
<li><strong>shock of any origin</strong></li>
</ul></li>
<li><p><strong>The residual gland is shrunken and scarred</strong></p></li>
<li><p><strong>Ablation of the pituitary by surgery or irradiation</strong></p></li>
<li><p><strong>Inflammatory lesions</strong></p>
<ul>
<li><strong>sarcoidosis or tuberculosis</strong></li>
</ul></li>
<li><p><strong>Trauma</strong></p></li>
<li><p><strong>Metastatic neoplasms involving the pituitary</strong></p></li>
</ul>
</section>

<section id="clinical-manifestations-of-anterior-pituitary-hypofunction" class="title-slide slide level1 center">
<h1>Clinical manifestations of anterior pituitary hypofunction</h1>
<ul>
<li><strong>Depend on the specific hormones that are lacking</strong></li>
<li><strong>Growth hormone deficiency</strong>
<ul>
<li><strong>Growth failure (pituitary dwarfism)</strong></li>
</ul></li>
<li><strong>Gonadotropin or gonadotropin-releasing hormone (GnRH) deficiency</strong>
<ul>
<li><strong>amenorrhea and infertility in women</strong></li>
<li><strong>decreased libido, impotence, and loss of pubic and axillary hair in men</strong></li>
</ul></li>
<li><strong>TSH</strong>
<ul>
<li><strong>hypothyroidism</strong></li>
</ul></li>
<li><strong>ACTH</strong>
<ul>
<li><strong>hypoadrenalism</strong></li>
</ul></li>
<li><strong>Prolactin deficiency</strong>
<ul>
<li><strong>failure of postpartum lactation</strong></li>
</ul></li>
<li><strong>Loss of stimulatory effects of MSH on melanocytes</strong>
<ul>
<li><strong>Pallor</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CPituitary-Diseases33.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases34.jpg"></p>
</section>

<section id="posterior-pituitary-syndromes" class="title-slide slide level1 center">
<h1>POSTERIOR PITUITARY SYNDROMES</h1>

</section>

<section id="posterior-pituitary-syndromes-1" class="title-slide slide level1 center">
<h1>Posterior Pituitary Syndromes</h1>
<ul>
<li><strong>Neurohypophysis</strong>
<ul>
<li><strong>composed of modified glial cells (termed pituicytes )</strong></li>
<li><strong>Axonal processes extending from nerve cell bodies in the supraoptic and paraventricular nuclei of the hypothalamus</strong></li>
</ul></li>
<li><strong>Hypothalamic neurons produce two peptides</strong>
<ul>
<li><strong>antidiuretic hormone (ADH) and oxytocin</strong></li>
<li><strong>They are stored in axon terminals in the neurohypophysis</strong></li>
<li><strong>Released into the circulation in response to stimuli</strong></li>
</ul></li>
<li><strong>Oxytocin</strong>
<ul>
<li><strong>stimulates the contraction of smooth muscle in the pregnant uterus</strong></li>
<li><strong>muscle surrounding the lactiferous ducts of the mammary glands</strong></li>
<li><strong>Impairment of oxytocin synthesis and release has not been associated with significant clinical abnormalities</strong></li>
</ul></li>
<li><strong>ADH</strong>
<ul>
<li><strong>diabetes insipidus</strong></li>
<li><strong>secretion of inappropriately high levels of ADH</strong></li>
</ul></li>
</ul>
</section>

<section id="antidiuretic-hormone" class="title-slide slide level1 center">
<h1>Antidiuretic hormone</h1>
<ul>
<li><strong>Synthesized predominantly in the supraoptic nucleus</strong></li>
<li><strong>ADH is released in response to</strong>
<ul>
<li><strong>Increased plasma oncotic pressure, left atrial distention, exercise, and certain emotional states</strong></li>
<li><strong>acts on the collecting tubules of the kidney to promote the resorption of free water</strong></li>
</ul></li>
<li><strong>ADH deficiency causes diabetes insipidus</strong>
<ul>
<li><p><strong>excessive urination (polyuria)</strong></p></li>
<li><p><strong>inability of the kidney to properly resorb water from the urine</strong></p></li>
<li><p><strong>Syndrome of inappropriate ADH (SIADH) secretion</strong></p>
<ul>
<li><strong>Resorption of excessive amounts of free water</strong></li>
<li><strong>Hyponatremia, cerebral edema, neurologic dysfunction</strong></li>
</ul></li>
<li><p><strong>ADH excess is caused by several extracranial and intracranial disorders</strong></p>
<ul>
<li><strong>secretion of ectopic ADH by malignant neoplasms</strong>
<ul>
<li><strong>small cell carcinomas of the lung</strong></li>
</ul></li>
<li><strong>non-neoplastic diseases of the lung</strong></li>
<li><strong>Local injury to the hypothalamus or neurohypophysis</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="hypothalamic-suprasellar-tumors" class="title-slide slide level1 center">
<h1>HYPOTHALAMIC SUPRASELLAR TUMORS</h1>

<img data-src="img%5CPituitary-Diseases35.png" class="r-stretch"><p><strong>Craniopharyngioma</strong></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="craniopharyngioma" class="title-slide slide level1 center">
<h1>Craniopharyngioma</h1>
<ul>
<li><p><strong>Arise from vestigial remnants of Rathke pouch</strong></p></li>
<li><p><strong>1-5% of intracranial tumors</strong></p></li>
<li><p><strong>Most are suprasellar, with or without intrasellar extension</strong></p></li>
<li><p><strong>Bimodal age distribution</strong></p>
<ul>
<li><strong>one peak in childhood (5 to 15 years)</strong></li>
<li><strong>second peak in adults 65 years or older</strong></li>
</ul></li>
<li><p><strong>Abnormalities of the WNT signaling pathway, mutations of Î²-catenin</strong></p></li>
<li><p><strong>Average 3-4â¯cm in diameter</strong></p></li>
<li><p><strong>Cystic and sometimes multiloculated</strong></p></li>
<li><p><strong>Adamantinomatous craniopharyngioma</strong></p>
<ul>
<li><strong>Children</strong></li>
<li><strong>Calcifications</strong></li>
<li><strong>cysts of adamantinomatous craniopharyngiomas often contain a cholesterol-rich, thick brownish-yellow fluid, âmachine oilâ</strong></li>
</ul></li>
<li><p><strong>Papillary craniopharyngioma</strong></p>
<ul>
<li><strong>most often observed in adults</strong></li>
</ul></li>
</ul>

<img data-src="img%5CPituitary-Diseases36.png" class="r-stretch"><p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="section" class="title-slide slide level1 center">
<h1></h1>

<img data-src="img%5CPituitary-Diseases37.png" class="r-stretch"></section>

<section id="hipofiz-adenomuna-yaklaÅÄ±m" class="title-slide slide level1 center">
<h1>Hipofiz adenomuna yaklaÅÄ±m</h1>

</section>

<section id="dr.-serdar-balcÄ±" class="title-slide slide level1 center">
<h1>Dr.&nbsp;Serdar BalcÄ±</h1>

</section>

<section id="klinik-bilgi" class="title-slide slide level1 center">
<h1>Klinik bilgi</h1>
<ul>
<li><strong>Ãocuklarda: PRL, ACTH</strong></li>
<li><strong>Hormon dÃ¼zeylerinde artÄ±Å</strong>
<ul>
<li><strong>Hiperprolaktinemi â nonspesifik</strong></li>
</ul></li>
<li><strong>Kitle etkisi</strong>
<ul>
<li><strong>BaÅaÄrÄ±sÄ±</strong></li>
<li><strong>GÃ¶rme alanÄ±</strong></li>
<li><strong>Hipopituitarism</strong></li>
</ul></li>
<li><strong>D. insipid ve kraniel sinir arazÄ±</strong>
<ul>
<li><strong>Ãncelikle diÄer tÃ¼mÃ¶rler, metastazlar</strong></li>
<li><strong>Ä°nflamatuar sÃ¼reÃ§ler</strong></li>
</ul></li>
</ul>
</section>

<section id="ameliyat" class="title-slide slide level1 center">
<h1>Ameliyat</h1>
<p><strong>EÄer hemen patolojiye gelecekse SF iÃ§eren tÃ¼pte gÃ¶nderilebilir. (Otoliz, formolsÃ¼z diye not konan rapor sayÄ±sÄ±)</strong></p>
<p><strong>GazlÄ± bezi unutun</strong></p>
<p><strong>Formaldehit</strong></p>
<p><strong>EM inceleme?</strong></p>
</section>

<section id="hipofiz-adenomu---frozen" class="title-slide slide level1 center">
<h1>Hipofiz adenomu - Frozen</h1>
<ul>
<li><strong>Doku genelde kÃ¼Ã§Ã¼k</strong>
<ul>
<li><strong>Donma artefaktÄ±</strong></li>
</ul></li>
<li><strong>Yayma</strong>
<ul>
<li><strong>Daha az doku yeterli</strong></li>
<li><strong>Deneyim gerektiriyor</strong></li>
</ul></li>
<li><strong>Tek tanÄ±sal materyal frozenda </strong> <em>harcanmÄ±Å </em> <strong>olabilir</strong></li>
<li><strong>Frozen beklenmedik bir bulgu ile karÅÄ±laÅÄ±nca uygulanabilir (baÅka tÃ¼mÃ¶r ÅÃ¼phesi)</strong></li>
<li><strong>Ä°ntraoperatif retikÃ¼lin?</strong></li>
<li><strong>Cerrahi sÄ±nÄ±r?</strong></li>
</ul>
</section>

<section id="mikroadenom-frozen" class="title-slide slide level1 center">
<h1>Mikroadenom â Frozen?</h1>

</section>

<section id="adenohipofiz" class="title-slide slide level1 center">
<h1>Adenohipofiz</h1>
<p><strong>LobÃ¼ler yapÄ±</strong></p>
<p><strong>CoÄrafi daÄÄ±lÄ±m</strong></p>
<p><strong>TÃ¼krÃ¼k bezi benzeri bezler gibi taklitÃ§iler</strong></p>
</section>

<section id="ara-lob" class="title-slide slide level1 center">
<h1>Ara lob???</h1>

</section>

<section id="nÃ¶rohipofiz" class="title-slide slide level1 center">
<h1>NÃ¶rohipofiz</h1>

</section>

<section id="suprasellar-kitleler---ddx" class="title-slide slide level1 center">
<h1>Suprasellar kitleler - Ddx</h1>
<p><strong>Pituisitom</strong></p>
<p><strong>Lenfositik/granÃ¼lamatÃ¶z hipofizit</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Gangliositom/Gangliositoadenom</strong></p>
<p><strong>Germ hÃ¼creli tÃ¼mÃ¶rler</strong></p>
<p><strong>GranÃ¼ler hÃ¼crrli tÃ¼mÃ¶r</strong></p>
<p><strong>Plazmasitom</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Paragangliom</strong></p>
<p><strong>Metastaz</strong></p>

<img data-src="img%5CPituitary-Diseases38.png" class="r-stretch"></section>

<section id="section-1" class="title-slide slide level1 center">
<h1></h1>

<img data-src="img%5CPituitary-Diseases39.png" class="r-stretch"></section>

<section id="sellar-kitleler" class="title-slide slide level1 center">
<h1>Sellar kitleler</h1>
<p><strong>Kraniyofarengiom</strong></p>
<p><strong>Rathke kleft kisti</strong></p>
<p><strong>Teratom</strong></p>
<p><strong>Kordoma</strong></p>
<p><strong>Germinom</strong></p>
<p><strong>Pilositik astrositom</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Ä°nflamasyon</strong></p>
<p><strong>Langerhans hÃ¼creli histiyositoz</strong></p>
<p><strong>GranÃ¼ler hÃ¼creli tÃ¼mÃ¶r</strong></p>
<p><strong>Glezer et al, Rare Sellar Lesions, Endocrinol Metab Clin N Am 37 (2008) 195â211</strong></p>
<p><img data-src="img%5CPituitary-Diseases40.png"></p>
<p><img data-src="img%5CPituitary-Diseases41.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases42.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases43.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases44.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases45.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases46.jpg"></p>
</section>

<section id="section-2" class="title-slide slide level1 center">
<h1></h1>
<p><strong>Postmortem prevalence of pituitary adenoma is 14.4% </strong></p>
<p><strong>radiologic studies identify a lesion consistent with pituitary adenoma in 22.2% of the population</strong></p>
<p><strong>providing an overall estimated prevalence of 16.9%.</strong></p>
</section>

<section id="adenom---hiperplazi" class="title-slide slide level1 center">
<h1>Adenom - Hiperplazi</h1>
<ul>
<li><strong>DiffÃ¼z, nodÃ¼ler</strong></li>
<li><strong>Hiperplazi</strong>
<ul>
<li><strong>Stimulus kesilince bÃ¼yÃ¼me durur</strong></li>
<li><strong>Gebelik: laktotrop hÃ¼cre proliferasyonu</strong></li>
<li><strong>Primer hipopituitarizm: tirotrop</strong></li>
<li><strong>Hipotalamik gangliositom, GHrH eksprese eden tÃ¼mÃ¶rler: somatotrop</strong></li>
<li>__ CrH: bronÅial, gastroenterohepatik, adrenal, prostat endokrin tÃ¼mÃ¶rler__</li>
</ul></li>
</ul>
<p><img data-src="img%5CPituitary-Diseases47.png"></p>
<p><img data-src="img%5CPituitary-Diseases48.png"></p>
<p><img data-src="img%5CPituitary-Diseases49.png"></p>
</section>

<section id="hipofiz-adenomu" class="title-slide slide level1 center">
<h1>Hipofiz adenomu</h1>

</section>

<section id="ffpe-he" class="title-slide slide level1 center">
<h1>FFPE â H&amp;E</h1>
<ul>
<li><strong>H&amp;E</strong></li>
<li><strong>10 boyasÄ±z</strong>
<ul>
<li><strong>RetikÃ¼lin</strong></li>
<li><strong>PAS?</strong></li>
<li><strong>MIB-1</strong></li>
<li><strong>p53</strong></li>
<li><strong>Hormonlar</strong></li>
</ul></li>
</ul>
<p><strong>NÃ¼kleus</strong></p>
<p><strong>NÃ¼kleol</strong></p>
<p><strong>Kromatin</strong></p>
<p><strong>Atipi?</strong></p>
<p><strong>Mitoz</strong></p>
<p><strong>Sitoplazma</strong></p>
<p><strong>YapÄ±</strong></p>
<p><strong>Papiller</strong></p>
<p><strong>Amiloid</strong></p>
<p><strong>Kalsifikasyon</strong></p>
<p><strong>Tedavi etkisi</strong></p>
</section>

<section id="retikÃ¼lin-adenohipofiz-hiperplazi-adenom" class="title-slide slide level1 center">
<h1>RetikÃ¼lin: Adenohipofiz, Hiperplazi, Adenom</h1>

</section>

<section id="hormon-belirteÃ§leri" class="title-slide slide level1 center">
<h1>Hormon belirteÃ§leri</h1>

</section>

<section id="gh" class="title-slide slide level1 center">
<h1>GH</h1>

</section>

<section id="gh-ck8" class="title-slide slide level1 center">
<h1>GH â CK8</h1>

</section>

<section id="prolaktin" class="title-slide slide level1 center">
<h1>Prolaktin</h1>

</section>

<section id="prolaktin-ck8" class="title-slide slide level1 center">
<h1>Prolaktin â CK8</h1>

</section>

<section id="tsh" class="title-slide slide level1 center">
<h1>TSH</h1>

</section>

<section id="fsh" class="title-slide slide level1 center">
<h1>FSH</h1>

</section>

<section id="lh" class="title-slide slide level1 center">
<h1>LH</h1>

</section>

<section id="acth" class="title-slide slide level1 center">
<h1>ACTH</h1>

</section>

<section id="acth---mikroadenom" class="title-slide slide level1 center">
<h1>ACTH - mikroadenom</h1>
<p><strong>RetikÃ¼lin ve ACTH IHKâsÄ± gerekli</strong></p>
<p><strong>YoÄun granÃ¼llÃ¼</strong></p>
<p><strong>Bazofilik hÃ¼creler</strong></p>
<p><strong>PAS +</strong></p>
<p><strong>CAM 5.2, CK7, CK8</strong></p>
</section>

<section id="acth--crooke-deÄiÅiklik" class="title-slide slide level1 center">
<h1>ACTH- Crooke deÄiÅiklik</h1>
<ul>
<li><strong>TÃ¼mÃ¶rsÃ¼z alanda (genellikle kortikotroplarda)</strong></li>
<li><strong>DolaÅÄ±mdaki artmÄ±Å glukokortikoid varlÄ±ÄÄ±nÄ± yansÄ±tÄ±r</strong>
<ul>
<li><strong>Pituiter kortikotrop adenom</strong></li>
<li><strong>Ektopik ACTH sekresyonu</strong></li>
<li><strong>Primer adrenal patolojiler</strong></li>
<li><strong>Ä°atrojenik</strong></li>
</ul></li>
<li><strong>Adenom gÃ¶rÃ¼lmediyse mikroadenom varlÄ±ÄÄ± araÅtÄ±rÄ±lmalÄ± (1-2 mmâlik seri kesitler, retikÃ¼lin ve ACTH ile bakÄ±larak)</strong></li>
<li><strong>Adenom gÃ¶rÃ¼lmezse klinikopatolojik korelasyon gerektirir</strong></li>
</ul>

<img data-src="img%5CPituitary-Diseases50.png" class="r-stretch"></section>

<section id="acth--crooke-cell" class="title-slide slide level1 center">
<h1>ACTH- Crooke cell</h1>
<ul>
<li><strong>Adenom gÃ¶rÃ¼lmediyse mikroadenom varlÄ±ÄÄ± araÅtÄ±rÄ±lmalÄ±</strong>
<ul>
<li><strong>1-2 mmâlik seri kesitler</strong></li>
<li><strong>RetikÃ¼lin ve ACTH ile bakÄ±larak</strong></li>
</ul></li>
<li><strong>Adenom gÃ¶rÃ¼lmezse klinikopatolojik korelasyon gerektirir</strong>
<ul>
<li><strong>HÃ¢lÃ¢ sellada adenom var mÄ±?</strong></li>
<li><strong>Kortikoid yÃ¼ksekliÄinin baÅka nedenleri</strong></li>
<li><strong>AspiratÃ¶rde ya da seri kesitlerde kaybolan adenom?</strong></li>
</ul></li>
</ul>
</section>

<section id="acth-crooke-deÄiÅiklik-yok-adenom-yok" class="title-slide slide level1 center">
<h1>ACTH Crooke deÄiÅiklik yok, adenom yok</h1>
<ul>
<li><strong>Kortikotrop hiperplazi?</strong>
<ul>
<li><strong>Patolojik deÄerlendirme zor olabilir</strong></li>
</ul></li>
<li><strong>PsÃ¶do Cushing</strong></li>
</ul>
</section>

<section id="acth-crooke-cell-adenoma" class="title-slide slide level1 center">
<h1>ACTH â Crooke cell adenoma</h1>
<p><strong>AdenomatÃ¶z hÃ¼crelerin sitoplazmasÄ±nda yoÄun birikim</strong></p>
<p><strong>NÃ¼kleer pleomorfizm, iri hÃ¼cre</strong></p>
<p><strong>DDX: gangliositom, metastaz</strong></p>
<p><strong>ACTH +</strong></p>
<p><strong>YoÄun halka Åeklinde keratin birikimi</strong></p>
<p><strong>CAM 5.2 +</strong></p>
</section>

<section id="p53" class="title-slide slide level1 center">
<h1>p53</h1>

</section>

<section id="ki-67" class="title-slide slide level1 center">
<h1>Ki-67</h1>

</section>

<section id="pit-1" class="title-slide slide level1 center">
<h1>Pit-1</h1>

</section>

<section id="er-Î±" class="title-slide slide level1 center">
<h1>ER-Î±</h1>

</section>

<section id="mukozada-ekilim" class="title-slide slide level1 center">
<h1>Mukozada ekilim?</h1>

</section>

<section id="serum-ihk-korelasyonu" class="title-slide slide level1 center">
<h1>Serum â IHK korelasyonu</h1>

</section>

<section id="otopside-inceleme" class="title-slide slide level1 center">
<h1>Otopside inceleme</h1>
<p><strong>Stalk yÃ¼ksekten kesilmeli</strong></p>
<p><strong>Sella kontrol edilmeli</strong></p>
<p><strong>Dorsum sella dan aÃ§Ä±larak intakt Ã§Ä±kartÄ±lmaya Ã§alÄ±ÅÄ±lmalÄ±</strong></p>

<img data-src="img%5CPituitary-Diseases51.png" class="r-stretch"></section>

<section id="alÄ±ntÄ±-slaytlar" class="title-slide slide level1 center">
<h1>AlÄ±ntÄ± slaytlar</h1>

</section>

<section id="section-3" class="title-slide slide level1 center">
<h1></h1>

</section>

<section id="adenohipofiz-1" class="title-slide slide level1 center">
<h1>Adenohipofiz</h1>
<p><strong>Lateral kanat</strong></p>
<p><strong>Mukoid wedge</strong></p>
<p><img data-src="img%5CPituitary-Diseases52.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases53.png"></p>
<p><img data-src="img%5CPituitary-Diseases54.png"></p>
<p><img data-src="img%5CPituitary-Diseases55.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases56.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases57.png"></p>
</section>

<section id="hipofiz-adenomu-sÄ±nÄ±flandÄ±rmasÄ±" class="title-slide slide level1 center">
<h1>Hipofiz adenomu sÄ±nÄ±flandÄ±rmasÄ±</h1>
<p><strong>Cerrahi, radyoloji</strong></p>
<ul>
<li><strong>Ä°nvazif</strong>
<ul>
<li><strong>Dura</strong></li>
<li><strong>Kemik</strong></li>
<li><strong>SinÃ¼sler</strong></li>
</ul></li>
<li><strong>Non-invazif</strong></li>
</ul>
<p><strong>Hormon aktif</strong></p>
<p><strong>Nonfonksiyone</strong></p>
<p><strong>Mikroadenom &lt;1cm</strong></p>
<p><strong>Makroadenom &gt;1cm</strong></p>
<p><img data-src="img%5CPituitary-Diseases58.png"></p>
<p><img data-src="img%5CPituitary-Diseases59.png"></p>
<p><img data-src="img%5CPituitary-Diseases60.png"></p>
<p><img data-src="img%5CPituitary-Diseases61.png"></p>
<p><img data-src="img%5CPituitary-Diseases62.png"></p>
<p><img data-src="img%5CPituitary-Diseases63.jpg"></p>
</section>

<section id="bÃ¼yÃ¼me-hormonu-adenomu" class="title-slide slide level1 center">
<h1>BÃ¼yÃ¼me Hormonu Adenomu</h1>
<p><strong>%10</strong></p>
<p><strong>%25-30</strong></p>
<p><strong>Gigantizm, akromegali</strong></p>
<p><strong>Ä°nvaziv makroadenom</strong></p>
<p><strong>IGF-1</strong></p>
</section>

<section id="yoÄun-granÃ¼llÃ¼-gh-adenomu" class="title-slide slide level1 center">
<h1>YoÄun granÃ¼llÃ¼ GH adenomu</h1>
<p><strong>Yuvarlak, polihedral, asidofilik</strong></p>
<p><strong>YaygÄ±n, kuvvetli sitoplazmik GH</strong></p>
<p><strong>PerinÃ¼kleer CK8</strong></p>
<p><strong>YarÄ±sÄ±nda Î±-subÃ¼nit pozitif</strong></p>
<p><strong>Pit-1 kuvvetli nÃ¼kleer pozitif</strong></p>
<p><strong>EM sekretuvar granÃ¼ller bol</strong></p>
</section>

<section id="seyrek-granÃ¼llÃ¼-gh-adenomu" class="title-slide slide level1 center">
<h1>Seyrek granÃ¼llÃ¼ GH adenomu</h1>
<ul>
<li><p><strong>KÃ¼Ã§Ã¼k, yuvarlak, kÄ±smen dÃ¼zensiz hÃ¼creler</strong></p></li>
<li><p><strong>FibrÃ¶z cisimler</strong></p>
<ul>
<li><strong>ParanÃ¼kleer soluk asidofilik kÃ¼resel inklÃ¼zyon</strong></li>
<li><strong>LMWCK, CK8 pozitif</strong></li>
</ul></li>
<li><p><strong>Pleomorfizm, Ã§ok Ã§ekirdekli bizar hÃ¼creler</strong></p></li>
<li><p><strong>GH zayÄ±f sitoplazmik</strong></p></li>
<li><p><strong>Pit-1 kuvvetli nÃ¼kleer pozitif</strong></p></li>
<li><p><strong>Daha agresif</strong></p></li>
<li><p><strong>MultinÃ¼kleer, pleomorfizm</strong></p>
<ul>
<li><strong>Prognostik deÄil</strong></li>
</ul></li>
<li><p><strong>Makroadenom, invazif</strong></p></li>
<li><p><strong>Otokrin</strong></p>
<ul>
<li><strong>GHrH salgÄ±lÄ±yor</strong></li>
</ul></li>
</ul>
</section>

<section id="prl-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>PRL hÃ¼cre adenomu</h1>
<ul>
<li><strong>%25-30</strong></li>
<li><strong>Serum PRL dÃ¼zeyi genelde tÃ¼mÃ¶r boyutu ile paralel</strong>
<ul>
<li><strong>&gt;150ng/mL tanÄ±sal</strong></li>
<li><strong>Daha dÃ¼ÅÃ¼k deÄerler basÄ± etkisini yansÄ±tÄ±r</strong></li>
</ul></li>
<li><strong>KadÄ±nlarda mikroadenom Åeklinde</strong>
<ul>
<li><strong>Galaktore, amenore</strong></li>
</ul></li>
<li><strong>Erkeklerde</strong>
<ul>
<li><strong>Libido azalmasÄ±, impotans</strong></li>
</ul></li>
<li><strong>Mikroadenom lateral ve posteriorda</strong></li>
<li><strong>Genelde diffÃ¼z, nadiren papiller</strong></li>
<li><strong>Nadir iri, uzun hÃ¼creler, belirgin membran</strong></li>
</ul>
<p><strong>Amiloid depolanmasÄ±, kalsifikasyon</strong></p>
<p><strong>PitÃ¼iter taÅ</strong></p>
</section>

<section id="seyrek-granÃ¼llÃ¼-laktotrop-adenomu" class="title-slide slide level1 center">
<h1>Seyrek granÃ¼llÃ¼ laktotrop adenomu</h1>
<ul>
<li><strong>Kromofob, amfofilik</strong>
<ul>
<li><strong>Belirgin </strong> <em>rough</em> __ endoplazmik retikulum iÃ§erir__</li>
</ul></li>
<li><strong>ParanÃ¼kleer (golgi) paterninde PRL pozitif</strong></li>
<li><strong>Pit-1 nÃ¼kleer kuvvetli</strong></li>
</ul>
</section>

<section id="yoÄun-granÃ¼llÃ¼-laktotrop-adenomu" class="title-slide slide level1 center">
<h1>YoÄun granÃ¼llÃ¼ laktotrop adenomu</h1>
<p><strong>Nadir</strong></p>
</section>

<section id="dopamin-agonisti-tedavisi-etkisi" class="title-slide slide level1 center">
<h1>Dopamin agonisti tedavisi etkisi</h1>
<p><strong>Atrofi</strong></p>
<p><strong>HÃ¼cre boyutunda kÃ¼Ã§Ã¼lme</strong></p>
<p><strong>Sitoplazmada bÃ¼zÃ¼Åme</strong></p>
<p><strong>N/C oranÄ±nda artma</strong></p>
<p><strong>Ä°nterstisyel ve perivaskÃ¼ler fibrozis</strong></p>
</section>

<section id="tsh-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>TSH hÃ¼cre adenomu</h1>
<p><strong>Nadir</strong></p>
<p><strong>Ä°nvaziv</strong></p>
<p><strong>Solid, sinÃ¼zoidal patern</strong></p>
<p><strong>Stromal fibrozis, psammom cisimleri</strong></p>
<p><strong>HÃ¼cre sÄ±nÄ±rlarÄ± belirsiz kromofob adenom</strong></p>
<p><strong>NÃ¼kleer pleomorfizm olabilir</strong></p>
<p><strong>PAS sitoplazmik granÃ¼ller</strong></p>
<p><strong>Sitoplazma: Î±-subÃ¼nit, Î²-TSH</strong></p>
<p><strong>NÃ¼kleer Pit-1</strong></p>
<p><strong>Plurihormonal ekspresyon izlenebilir</strong></p>
</section>

<section id="acth-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>ACTH hÃ¼cre adenomu</h1>
<ul>
<li><strong>%10-15</strong></li>
<li><strong>Makroskopik: kÄ±rmÄ±zÄ± ve yumuÅak mikroadenom</strong></li>
<li><strong>Seri kesitlere raÄmen izlenemeyebilir</strong></li>
<li><strong>Nadir kavernÃ¶z sinÃ¼s invazyonu</strong>
<ul>
<li><strong>Klinik ve biyokimyasal semptom yok</strong></li>
<li><strong>Sessiz</strong></li>
</ul></li>
</ul>
<p><strong>DiffÃ¼z, sinÃ¼zoidal</strong></p>
<p><strong>Bazofilik, amfofilik, monomorfik, yuvarlak</strong></p>
<p><strong>Kuvvetli PAS pozitif</strong></p>
<p><strong>Crooke hyalen deÄiÅim</strong></p>
<p><strong>Pleomorfizm</strong></p>
<p><strong>Mitoz nadir</strong></p>
<p><strong>ACTH, Î²-LPH ve/veya Î²-endorfin</strong></p>
<p><strong>Cushing hastalÄ±ÄÄ± (pitÃ¼iter ACTH fazlalÄ±ÄÄ±)</strong></p>
<p><strong>Nelson zemininde geliÅen</strong></p>
<p><strong>Crooke cell adenoma</strong></p>
<p><strong>Sessiz kortikotrop adenomlar</strong></p>
</section>

<section id="cushing-hastalÄ±ÄÄ±-pitÃ¼iter-acth-fazlalÄ±ÄÄ±" class="title-slide slide level1 center">
<h1>Cushing hastalÄ±ÄÄ± (pitÃ¼iter ACTH fazlalÄ±ÄÄ±)</h1>

</section>

<section id="gonadotrop-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>Gonadotrop hÃ¼cre adenomu</h1>
<p><strong>Nadir?</strong></p>
<p><strong>Fonksiyonel olanlar erkeklerde daha sÄ±k</strong></p>
<p><strong>Sessiz adenomlarda IHK ile tanÄ± konur</strong></p>
<p><strong>Makroadenom</strong></p>
<p><strong>Supra, parasellar</strong></p>
<p><strong>SinÃ¼zoid, psÃ¶dorozet</strong></p>
<p><strong>Kanama, nekroz olabilir</strong></p>
<p><strong>PAS negatif, onkositik olabilir</strong></p>
<p><strong>Î±-subÃ¼nit, Î²-FSH (daha sÄ±k), Î²-LH pozitif</strong></p>
</section>

<section id="plurihormonal-adenomlar" class="title-slide slide level1 center">
<h1>Plurihormonal Adenomlar</h1>
<ul>
<li><strong>Pit-1</strong>
<ul>
<li><strong>KarÄ±ÅÄ±k somatotrop-laktotrop</strong>
<ul>
<li><strong>Akromegali, stalka basÄ±</strong></li>
<li><strong>Ä°ki farklÄ± hÃ¼cre tipi</strong></li>
</ul></li>
<li><strong>Mammosomatotrop</strong>
<ul>
<li><strong>Klinik sakin, akromegali, hiperPRL</strong></li>
<li><strong>AynÄ± hÃ¼crede GH ve PRL</strong></li>
</ul></li>
<li><strong>Asidofil kÃ¶k hÃ¼cre</strong>
<ul>
<li><strong>Klinik sakin veya hiperPRL</strong></li>
<li><strong>Kromofob</strong></li>
<li><strong>Ä°nvaziv</strong></li>
<li><strong>ParanÃ¼kleer vakuol</strong></li>
<li><strong>Agresif seyir</strong></li>
</ul></li>
<li><strong>Plurihormonal GH Ã¼reten adenomlar</strong>
<ul>
<li><strong>YoÄun granÃ¼llÃ¼ GH adenomu</strong></li>
<li><strong>PRL, Î±-subÃ¼nit, Î²-TSH, Î²-FSH, Î²-LH</strong></li>
</ul></li>
</ul></li>
<li><strong>ACTH-Î± subÃ¼nit</strong></li>
<li><strong>LH/FSH-PRL-Î²-endorfin</strong></li>
<li><strong>GH-ACTH</strong></li>
<li><strong>PRL-TSH</strong></li>
</ul>
</section>

<section id="null-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>Null HÃ¼cre Adenomu</h1>
<p><strong>%20, giderek dÃ¼ÅÃ¼yor</strong></p>
<p><strong>Suprasellar, parasellar invazyon</strong></p>
<p><strong>Kavitasyon, kanama</strong></p>
<p><strong>Yuvarlak, poligonal, kromofob</strong></p>
<p><strong>DiffÃ¼z, papiller</strong></p>
<p><strong>Pleomorfizm, mitoz nadir</strong></p>
</section>

<section id="invaziv" class="title-slide slide level1 center">
<h1>Ä°nvaziv</h1>
<p><strong>Kemik</strong></p>
<p><strong>KavernÃ¶z sinÃ¼s</strong></p>
<p><strong>Nazofarenks</strong></p>
<p><strong>Dura</strong></p>
<ul>
<li><strong>Agresif davranÄ±Å</strong>
<ul>
<li><strong>RekÃ¼rrens</strong></li>
<li><strong>Hormon dÃ¼zeyi normale dÃ¶nmez</strong></li>
</ul></li>
<li><strong>Dura invazyonu sÄ±k</strong>
<ul>
<li><strong>Agresif deÄil</strong></li>
</ul></li>
</ul>
</section>

<section id="atipik-adenom" class="title-slide slide level1 center">
<h1>Atipik adenom</h1>
<ul>
<li><strong>Biyolojik</strong>
<ul>
<li><strong>Agresif davranÄ±Å</strong></li>
<li><strong>RekÃ¼rrens</strong></li>
</ul></li>
<li><strong>Ki-67&gt;%3</strong></li>
<li><strong>p53 pozitif</strong></li>
<li><strong>Metastaz yaparlar mÄ±?</strong></li>
</ul>
</section>

<section id="hipofiz-karsinomu" class="title-slide slide level1 center">
<h1>Hipofiz karsinomu</h1>
<ul>
<li><strong>BOS ya da sistemik yayÄ±lÄ±mla tanÄ± konur</strong></li>
<li><strong>EriÅkinlerde</strong></li>
<li><strong>Nadir</strong></li>
<li><strong>PRL, GH</strong></li>
<li><strong>ACTH olanlar Nelson zemininde</strong></li>
<li><strong>Ä°nvazyon, pleomorfizm, mitoz ve nekroz izlenir</strong>
<ul>
<li><strong>Ancak tanÄ±sal ya da prediktif deÄildir</strong></li>
</ul></li>
</ul>
</section>

<section id="cadillac-approach" class="title-slide slide level1 center">
<h1>Cadillac approach</h1>
<p><strong>Acta Neuropathol (2006) 111: 68â70</strong></p>
</section>

<section id="section-4" class="title-slide slide level1 center">
<h1></h1>
<p><img data-src="img%5CPituitary-Diseases64.png"></p>
<p><img data-src="img%5CPituitary-Diseases65.png"></p>
</section>

<section id="hipofiz-adenomu-1" class="title-slide slide level1 center">
<h1>Hipofiz adenomu</h1>

</section>

<section id="dialar" class="title-slide slide level1 center">
<h1>dialar</h1>
<p><img data-src="img%5CPituitary-Diseases66.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases67.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases68.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases69.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases70.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases71.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases72.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases73.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases74.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases75.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases76.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases77.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases78.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases79.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases80.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases81.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases82.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases83.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases84.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases85.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases86.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases87.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases88.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases89.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases90.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases91.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases92.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases93.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases94.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases95.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases96.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases97.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases98.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases99.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases100.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases101.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases102.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases103.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases104.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases105.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases106.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases107.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases108.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases109.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases110.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases111.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases112.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases113.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases114.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases115.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases116.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases117.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases118.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases119.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases120.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases121.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases122.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases123.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases124.jpg"></p>
<p><img data-src="img%5CPituitary-Diseases125.jpg"></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="pituitary-diseases_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="pituitary-diseases_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="pituitary-diseases_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="pituitary-diseases_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "KopyalandÄ±");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "KopyalandÄ±");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>